Loading...

China Healthcare Enterprise Group

SEHK:1143
Snowflake Description

Flawless balance sheet and overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
1143
SEHK
HK$476M
Market Cap
  1. Home
  2. HK
  3. Tech
Company description

China Healthcare Enterprise Group Limited, an investment holding company, provides electronics manufacturing services for telecommunications, security, car electronics, home appliances, other consumer, and industrial electronic products. The last earnings update was 21 days ago. More info.


Add to Portfolio Compare Print
  • China Healthcare Enterprise Group has significant price volatility in the past 3 months.
1143 Share Price and Events
7 Day Returns
-3.6%
SEHK:1143
-7.4%
HK Electronic
-2.5%
HK Market
1 Year Returns
-63.6%
SEHK:1143
-40.2%
HK Electronic
-15.9%
HK Market
1143 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
China Healthcare Enterprise Group (1143) -3.6% -25.9% 2.6% -63.6% -87.3% 3.9%
HK Electronic -7.4% -18.5% -11.6% -40.2% 4.1% 20.9%
HK Market -2.5% -8.6% -2.1% -15.9% 25.4% 7.8%
1 Year Return vs Industry and Market
  • 1143 underperformed the Electronic industry which returned -40.2% over the past year.
  • 1143 underperformed the Market in Hong Kong which returned -15.9% over the past year.
Price Volatility
1143
Industry
5yr Volatility vs Market

1143 Value

 Is China Healthcare Enterprise Group undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for China Healthcare Enterprise Group. This is due to cash flow or dividend data being unavailable. The share price is HK$0.08.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for China Healthcare Enterprise Group's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are China Healthcare Enterprise Group's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
SEHK:1143 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in HKD HK$-0.01
SEHK:1143 Share Price ** SEHK (2019-05-17) in HKD HK$0.08
Hong Kong Electronic Industry PE Ratio Median Figure of 59 Publicly-Listed Electronic Companies 11.11x
Hong Kong Market PE Ratio Median Figure of 1,476 Publicly-Listed Companies 11.17x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of China Healthcare Enterprise Group.

SEHK:1143 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= SEHK:1143 Share Price ÷ EPS (both in HKD)

= 0.08 ÷ -0.01

-8.2x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • China Healthcare Enterprise Group is loss making, we can't compare its value to the HK Electronic industry average.
  • China Healthcare Enterprise Group is loss making, we can't compare the value of its earnings to the Hong Kong market.
Price based on expected Growth
Does China Healthcare Enterprise Group's expected growth come at a high price?
Raw Data
SEHK:1143 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -8.2x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Hong Kong Electronic Industry PEG Ratio Median Figure of 13 Publicly-Listed Electronic Companies 0.64x
Hong Kong Market PEG Ratio Median Figure of 463 Publicly-Listed Companies 0.79x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for China Healthcare Enterprise Group, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on China Healthcare Enterprise Group's assets?
Raw Data
SEHK:1143 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in HKD HK$0.10
SEHK:1143 Share Price * SEHK (2019-05-17) in HKD HK$0.08
Hong Kong Electronic Industry PB Ratio Median Figure of 83 Publicly-Listed Electronic Companies 1.19x
Hong Kong Market PB Ratio Median Figure of 2,155 Publicly-Listed Companies 0.97x
SEHK:1143 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= SEHK:1143 Share Price ÷ Book Value per Share (both in HKD)

= 0.08 ÷ 0.10

0.83x

* Primary Listing of China Healthcare Enterprise Group.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • China Healthcare Enterprise Group is good value based on assets compared to the HK Electronic industry average.
X
Value checks
We assess China Healthcare Enterprise Group's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Electronic industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Electronic industry average (and greater than 0)? (1 check)
  5. China Healthcare Enterprise Group has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

1143 Future Performance

 How is China Healthcare Enterprise Group expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as China Healthcare Enterprise Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
18.4%
Expected Electronic industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is China Healthcare Enterprise Group expected to grow at an attractive rate?
  • Unable to compare China Healthcare Enterprise Group's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare China Healthcare Enterprise Group's earnings growth to the Hong Kong market average as no estimate data is available.
  • Unable to compare China Healthcare Enterprise Group's revenue growth to the Hong Kong market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
SEHK:1143 Future Growth Rates Data Sources
Data Point Source Value (per year)
Hong Kong Electronic Industry Earnings Growth Rate Market Cap Weighted Average 18.4%
Hong Kong Electronic Industry Revenue Growth Rate Market Cap Weighted Average 12.5%
Hong Kong Market Earnings Growth Rate Market Cap Weighted Average 11.4%
Hong Kong Market Revenue Growth Rate Market Cap Weighted Average 10.7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
SEHK:1143 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in HKD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
SEHK:1143 Past Financials Data
Date (Data in HKD Millions) Revenue Cash Flow Net Income *
2018-12-31 735 -96 -58
2018-09-30 695 -81 -75
2018-06-30 655 -66 -92
2018-03-31 658 -51 -110
2017-12-31 662 -36 -128
2017-09-30 668 -62 -140
2017-06-30 674 -88 -152
2017-03-31 711 -47 -117
2016-12-31 749 -6 -83
2016-06-30 912 55 4
2016-03-31 960 35 41

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if China Healthcare Enterprise Group is high growth as no earnings estimate data is available.
  • Unable to determine if China Healthcare Enterprise Group is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
SEHK:1143 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from China Healthcare Enterprise Group Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SEHK:1143 Past Financials Data
Date (Data in HKD Millions) EPS *
2018-12-31 -0.01
2018-09-30 -0.01
2018-06-30 -0.02
2018-03-31 -0.02
2017-12-31 -0.03
2017-09-30 -0.03
2017-06-30 -0.03
2017-03-31 -0.02
2016-12-31 -0.02
2016-06-30 0.00
2016-03-31 0.01

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if China Healthcare Enterprise Group will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine China Healthcare Enterprise Group's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. China Healthcare Enterprise Group's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Tech companies here
  3. China Healthcare Enterprise Group's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess China Healthcare Enterprise Group's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Hong Kong market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Hong Kong market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
China Healthcare Enterprise Group has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

1143 Past Performance

  How has China Healthcare Enterprise Group performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare China Healthcare Enterprise Group's growth in the last year to its industry (Electronic).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • China Healthcare Enterprise Group does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare China Healthcare Enterprise Group's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare China Healthcare Enterprise Group's 1-year growth to the HK Electronic industry average as it is not currently profitable.
Earnings and Revenue History
China Healthcare Enterprise Group's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from China Healthcare Enterprise Group Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SEHK:1143 Past Revenue, Cash Flow and Net Income Data
Date (Data in HKD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 735.18 -57.98 214.30
2018-09-30 694.87 -75.23 218.40
2018-06-30 654.56 -92.48 222.50
2018-03-31 658.38 -110.46 209.79
2017-12-31 662.21 -128.43 197.07
2017-09-30 668.12 -140.39 190.77
2017-06-30 674.03 -152.34 184.46
2017-03-31 711.39 -117.49 182.91
2016-12-31 748.75 -82.65 181.36
2016-06-30 911.86 4.41 147.43
2016-03-31 960.21 41.00 140.28
2015-12-31 1,008.56 77.59 133.13
2015-06-30 720.58 140.97 46.44
2015-03-31 876.77 115.48 93.82
2014-12-31 1,032.96 89.99 141.20
2014-09-30 1,876.18 12.85 329.25
2014-06-30 1,919.50 25.12 307.64
2014-03-31 1,872.52 26.84 293.40
2013-12-31 1,825.54 28.57 279.17
2013-09-30 1,688.88 23.21 261.86
2013-06-30 1,552.22 17.86 244.55
2013-03-31 1,505.21 20.60 230.72
2012-12-31 1,458.19 23.35 216.89
2012-09-30 1,400.05 33.04 207.33
2012-06-30 1,341.90 42.73 197.77

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if China Healthcare Enterprise Group has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if China Healthcare Enterprise Group has efficiently used its assets last year compared to the HK Electronic industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if China Healthcare Enterprise Group improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess China Healthcare Enterprise Group's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Electronic industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
China Healthcare Enterprise Group has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

1143 Health

 How is China Healthcare Enterprise Group's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up China Healthcare Enterprise Group's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • China Healthcare Enterprise Group is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • China Healthcare Enterprise Group has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of China Healthcare Enterprise Group's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 18.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from China Healthcare Enterprise Group Company Filings, last reported 4 months ago.

SEHK:1143 Past Debt and Equity Data
Date (Data in HKD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 582.83 40.27 367.68
2018-09-30 582.83 40.27 367.68
2018-06-30 586.81 42.82 377.99
2018-03-31 586.81 42.82 377.99
2017-12-31 654.00 43.14 496.11
2017-09-30 654.00 43.14 496.11
2017-06-30 392.43 28.07 331.20
2017-03-31 392.43 28.07 331.20
2016-12-31 463.64 79.71 342.38
2016-06-30 561.49 0.00 353.66
2016-03-31 561.49 0.00 353.66
2015-12-31 548.00 0.00 444.94
2015-06-30 314.17 108.96 158.00
2015-03-31 314.17 108.96 158.00
2014-12-31 351.55 117.08 190.54
2014-09-30 351.55 117.08 190.54
2014-06-30 372.67 99.49 137.48
2014-03-31 372.67 99.49 137.48
2013-12-31 390.39 111.81 191.05
2013-09-30 390.39 111.81 191.05
2013-06-30 366.66 86.63 139.87
2013-03-31 366.66 86.63 139.87
2012-12-31 363.78 79.93 167.33
2012-09-30 363.78 79.93 167.33
2012-06-30 338.43 50.98 154.37
  • China Healthcare Enterprise Group's level of debt (6.9%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (28.6% vs 6.9% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • China Healthcare Enterprise Group has sufficient cash runway for 2.7 years based on current free cash flow.
  • China Healthcare Enterprise Group has sufficient cash runway for 2 years if free cash flow continues to grow at historical rates of 74.2% each year.
X
Financial health checks
We assess China Healthcare Enterprise Group's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. China Healthcare Enterprise Group has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

1143 Dividends

 What is China Healthcare Enterprise Group's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from China Healthcare Enterprise Group dividends.
If you bought HK$2,000 of China Healthcare Enterprise Group shares you are expected to receive HK$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate China Healthcare Enterprise Group's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate China Healthcare Enterprise Group's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
SEHK:1143 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Hong Kong Electronic Industry Average Dividend Yield Market Cap Weighted Average of 39 Stocks 3.1%
Hong Kong Market Average Dividend Yield Market Cap Weighted Average of 968 Stocks 3.6%
Hong Kong Minimum Threshold Dividend Yield 10th Percentile 1.2%
Hong Kong Bottom 25% Dividend Yield 25th Percentile 2.1%
Hong Kong Top 25% Dividend Yield 75th Percentile 5.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

SEHK:1143 Past Annualized Dividends Data
Date (Data in HK$) Dividend per share (annual) Avg. Yield (%)
2016-09-13 0.000 0.000
2016-08-25 0.000 0.000
2016-04-25 0.000 0.000
2016-03-22 0.000 0.000
2015-09-10 0.000 0.000
2015-08-24 0.000 0.000
2015-04-23 0.003 1.248
2015-03-27 0.003 3.134
2014-04-24 0.004 5.631
2014-03-21 0.004 5.847
2013-04-18 0.004 7.412
2013-03-22 0.004 8.917
2012-08-29 0.005 10.972
2012-03-30 0.006 11.433
2011-08-19 0.004 7.713
2011-03-25 0.002 1.961

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as China Healthcare Enterprise Group has not reported any payouts.
  • Unable to verify if China Healthcare Enterprise Group's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of China Healthcare Enterprise Group's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as China Healthcare Enterprise Group has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess China Healthcare Enterprise Group's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can China Healthcare Enterprise Group afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. China Healthcare Enterprise Group has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

1143 Management

 What is the CEO of China Healthcare Enterprise Group's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Shimon Szmigiel
AGE 67
TENURE AS CEO 9.6 years
CEO Bio

Mr. Shimon Szmigiel serves as Chief Executive Officer at TrekStor GmbH. Mr. Szmigiel serves as Managing Director of Trekstor GmbH & Co. KG. He has been the Chief Executive Officer of TrekStor (Germany) at China Healthcare Enterprise Group Limited since October 2009. He has been a Director of TrekStor (Germany) since October 2009. He was educated in Israel at a "Kibbutz" and graduated from a high school in Mannheim, Germany.

CEO Compensation
  • Insufficient data for Shimon to compare compensation growth.
  • Insufficient data for Shimon to establish whether their remuneration is reasonable compared to companies of similar size in Hong Kong.
Management Team Tenure

Average tenure and age of the China Healthcare Enterprise Group management team in years:

9
Average Tenure
45
Average Age
  • The average tenure for the China Healthcare Enterprise Group management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Shaoxiang Gong

TITLE
Chairman of the Board
COMPENSATION
HK$1M
AGE
45

Chuanhong Duan

TITLE
Executive Director
COMPENSATION
HK$999K
AGE
30

Joshua Lee

TITLE
Company Secretary & Executive Director
COMPENSATION
HK$2M
AGE
44
TENURE
3.5 yrs

Dwight Sakuma

TITLE
President of TFNA (US)
AGE
67
TENURE
10.3 yrs

Shimon Szmigiel

TITLE
Chief Executive Officer of TrekStor (Germany) and Director of TrekStor (Germany)
AGE
67
TENURE
9.6 yrs

Dean Mercier

TITLE
Chief Executive Officer of GAEMS
AGE
56
TENURE
9 yrs

Xavier Dupont

TITLE
Chief Executive Officer of M&F Holdings Ltd.
AGE
40
TENURE
6.6 yrs
Board of Directors Tenure

Average tenure and age of the China Healthcare Enterprise Group board of directors in years:

3.5
Average Tenure
47.5
Average Age
  • The tenure for the China Healthcare Enterprise Group board of directors is about average.
Board of Directors

Shaoxiang Gong

TITLE
Chairman of the Board
COMPENSATION
HK$1M
AGE
45
TENURE
3.5 yrs

Chuanhong Duan

TITLE
Executive Director
COMPENSATION
HK$999K
AGE
30
TENURE
1.9 yrs

Joshua Lee

TITLE
Company Secretary & Executive Director
COMPENSATION
HK$2M
AGE
44
TENURE
3.5 yrs

Shimon Szmigiel

TITLE
Chief Executive Officer of TrekStor (Germany) and Director of TrekStor (Germany)
AGE
67
TENURE
9.6 yrs

Jinqiao Bao

TITLE
Independent Non-Executive Director
COMPENSATION
HK$560K
AGE
53
TENURE
3.5 yrs

Chun Hung Wong

TITLE
Independent Non-Executive Director
COMPENSATION
HK$280K
AGE
45
TENURE
3.5 yrs

Yuyun Cao

TITLE
Non-Executive Director
COMPENSATION
HK$2M
AGE
57
TENURE
3.5 yrs

Pok Man Leung

TITLE
Independent Non-Executive Director
COMPENSATION
HK$280K
AGE
50
TENURE
3.5 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (HK$) Value (HK$)
X
Management checks
We assess China Healthcare Enterprise Group's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. China Healthcare Enterprise Group has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

1143 News

Simply Wall St News

Could China Healthcare Enterprise Group Limited's (HKG:1143) Investor Composition Influence The Stock Price?

Every investor in China Healthcare Enterprise Group Limited (HKG:1143) should be aware of the most powerful shareholder groups. … Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. … With a market capitalization of HK$523m, China Healthcare Enterprise Group is a small cap stock, so it might not be well known by many institutional investors.

Simply Wall St -

Some China Healthcare Enterprise Group (HKG:1143) Shareholders Have Taken A Painful 88% Share Price Drop

So spare a thought for the long term shareholders of China Healthcare Enterprise Group Limited (HKG:1143); the share price is down a whopping 88% in the last three years. … China Healthcare Enterprise Group isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. … Over the last three years, China Healthcare Enterprise Group's revenue dropped 13% per year.

Simply Wall St -

Do Institutions Own China Healthcare Enterprise Group Limited (HKG:1143) Shares?

The big shareholder groups in China Healthcare Enterprise Group Limited (HKG:1143) have power over the company. … With a market capitalization of HK$476m, China Healthcare Enterprise Group is a small cap stock, so it might not be well known by many institutional investors. … See our latest analysis for China Healthcare Enterprise Group

Simply Wall St -

Do Institutions Own Shares In China Healthcare Enterprise Group Limited (HKG:1143)?

If you want to know who really controls China Healthcare Enterprise Group Limited (HKG:1143), then you'll have to look at the makeup of its share registry. … With a market capitalization of HK$499.4m, China Healthcare Enterprise Group is a small cap stock, so it might not be well known by many institutional investors. … See our latest analysis for China Healthcare Enterprise Group

Simply Wall St -

Are China Healthcare Enterprise Group Limited's (HKG:1143) Interest Costs Too High?

China Healthcare Enterprise Group Limited (HKG:1143) is a small-cap stock with a market capitalization of HK$1.08b. … While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health. … Electronic companies,

Simply Wall St -

1143 Company Info

Description

China Healthcare Enterprise Group Limited, an investment holding company, provides electronics manufacturing services for telecommunications, security, car electronics, home appliances, other consumer, and industrial electronic products. It is also involved in the trading of personal care products, business telephone systems, telecommunication products, and medical equipment; manufacture and sale of telecommunications and other, and consumable electronic products; and provision of Internet financial, EMS agency, and catering services. In addition, the company engages in the property investment, and securities and other assets investment activities. It operates in the People’s Republic of China, the United States, Switzerland, France, Poland, the United Kingdom, and internationally. The company was formerly known as Telefield International (Holdings) Limited and changed its name to China Healthcare Enterprise Group Limited in March 2016. China Healthcare Enterprise Group Limited was founded in 1992 and is based in Central, Hong Kong.

Details
Name: China Healthcare Enterprise Group Limited
1143
Exchange: SEHK
Founded: 1992
HK$475,624,912
5,945,311,400
Website: http://www.chinahealthcare.com.hk
Address: China Healthcare Enterprise Group Limited
Two International Finance Centre,
Suites 5815-5816,
Central,
Hong Kong
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
SEHK 1143 Ordinary Shares The Stock Exchange of Hong Kong Ltd. HK HKD 27. Jan 2011
Number of employees
Current staff
Staff numbers
1,600
China Healthcare Enterprise Group employees.
Industry
Electronic Manufacturing Services
Tech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/05/19 13:02
End of day share price update: 2019/05/17 00:00
Last earnings filing: 2019/04/28
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.